1. Home
  2. ALBT vs PPCB Comparison

ALBT vs PPCB Comparison

Compare ALBT & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.88

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.21

Market Cap

5.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALBT
PPCB
Founded
2014
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALBT
PPCB
Price
$0.88
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
151.4K
3.2M
Earning Date
03-30-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,611,940.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.51
$0.16
52 Week High
$11.66
$11.00

Technical Indicators

Market Signals
Indicator
ALBT
PPCB
Relative Strength Index (RSI) 44.48 34.63
Support Level $0.51 $0.16
Resistance Level $0.91 $0.24
Average True Range (ATR) 0.08 0.04
MACD 0.03 0.02
Stochastic Oscillator 76.64 29.09

Price Performance

Historical Comparison
ALBT
PPCB

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: